Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: Is there a lead-time bias?

Author： Huo Teh-Ia   Huang Yi-Hsiang   Chiang Jen-Huei   Wu Jaw-Ching   Lee Pui-Ching   Chi Chin-Wen   Lee Shou-Dong  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.42, Iss.4, 2007-01, pp. : 485-492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Locoregional Therapy for Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 4, Iss. 3, 2015-06 ,pp. : 163-164

Karger

Access to resources Recommend Favorite

Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis

By  

Liver Cancer, Vol. 5, Iss. 3, 2016-05 ,pp. : 175-189

Karger

Access to resources Recommend Favorite

Multimodal Treatment Strategies in Patients Undergoing Surgery for Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 31, Iss. 1, 2013-06 ,pp. : 112-117

Karger

Access to resources Recommend Favorite

Clinical Trials of Combined Molecular Targeted Therapy and Locoregional Therapy in Hepatocellular Carcinoma: Past, Present, and Future

By  

Liver Cancer, Vol. 3, Iss. 1, 2014-02 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Survival Benefit of Cirrhotic Patients with Hepatocellular Carcinoma Treated by Percutaneous Ethanol Injection as a Salvage Therapy

By Huo Teh-Ia   Huang Yi-Hsiang   Wu Jaw-Ching   Lee Pui-Ching   Chang Full-Young   Lee Shou-Dong  

Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 3, 2002-03 ,pp. : 350-355

Informa Healthcare

Access to resources Recommend Favorite